DE RONCHI, DIANA
 Distribuzione geografica
Continente #
NA - Nord America 14.771
AS - Asia 11.169
EU - Europa 9.674
AF - Africa 846
SA - Sud America 740
Continente sconosciuto - Info sul continente non disponibili 499
OC - Oceania 54
Totale 37.753
Nazione #
US - Stati Uniti d'America 14.498
IT - Italia 3.166
SG - Singapore 2.984
CN - Cina 2.864
VN - Vietnam 2.367
GB - Regno Unito 1.822
DE - Germania 1.097
HK - Hong Kong 1.005
SE - Svezia 831
FR - Francia 673
BR - Brasile 539
IN - India 512
UA - Ucraina 442
RU - Federazione Russa 441
BD - Bangladesh 394
SC - Seychelles 286
IE - Irlanda 276
NL - Olanda 255
KR - Corea 234
CI - Costa d'Avorio 196
JP - Giappone 191
ZA - Sudafrica 171
JO - Giordania 146
CA - Canada 131
EE - Estonia 125
FI - Finlandia 109
TG - Togo 102
MX - Messico 77
BG - Bulgaria 75
AR - Argentina 73
PH - Filippine 60
ID - Indonesia 58
CH - Svizzera 55
AT - Austria 51
ES - Italia 51
PK - Pakistan 48
AU - Australia 45
PL - Polonia 45
TR - Turchia 45
IQ - Iraq 43
BE - Belgio 36
EC - Ecuador 35
TH - Thailandia 35
CL - Cile 26
CO - Colombia 25
GR - Grecia 23
SA - Arabia Saudita 23
UZ - Uzbekistan 20
MY - Malesia 18
TW - Taiwan 16
IL - Israele 15
LT - Lituania 15
JM - Giamaica 14
LB - Libano 13
MA - Marocco 13
NO - Norvegia 13
PY - Paraguay 13
KE - Kenya 12
NP - Nepal 12
AE - Emirati Arabi Uniti 11
DK - Danimarca 11
PE - Perù 11
CR - Costa Rica 10
EG - Egitto 10
ET - Etiopia 10
VE - Venezuela 10
KZ - Kazakistan 9
TN - Tunisia 9
DZ - Algeria 8
NG - Nigeria 8
NZ - Nuova Zelanda 8
RO - Romania 8
HU - Ungheria 7
CZ - Repubblica Ceca 6
HN - Honduras 6
IR - Iran 6
PT - Portogallo 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
NI - Nicaragua 5
SI - Slovenia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
GE - Georgia 4
GT - Guatemala 4
KW - Kuwait 4
MK - Macedonia 4
OM - Oman 4
SV - El Salvador 4
UY - Uruguay 4
AL - Albania 3
BY - Bielorussia 3
HR - Croazia 3
KG - Kirghizistan 3
LV - Lettonia 3
MD - Moldavia 3
MT - Malta 3
RS - Serbia 3
SY - Repubblica araba siriana 3
UG - Uganda 3
Totale 37.202
Città #
Singapore 1.951
Southend 1.480
Ashburn 1.345
Fairfield 1.334
Hong Kong 932
Cambridge 913
Santa Clara 852
San Jose 804
Woodbridge 618
Seattle 611
Chandler 602
Wilmington 576
Hefei 557
Houston 555
Ho Chi Minh City 515
Bologna 511
Hanoi 452
Ann Arbor 446
Council Bluffs 426
Dong Ket 402
Princeton 398
Beijing 384
Boardman 293
Jacksonville 292
Dublin 272
Los Angeles 235
Lauterbourg 232
Rome 221
Milan 220
Seoul 219
Dallas 208
Abidjan 196
New York 184
Nanjing 174
Tokyo 165
Westminster 162
Padova 153
Amman 146
Buffalo 128
Berlin 114
Lomé 102
Saint Petersburg 99
Turin 94
The Dalles 89
Jinan 84
San Diego 81
Helsinki 79
Redondo Beach 76
Sofia 72
Shenyang 71
Guangzhou 70
Mülheim 70
Florence 66
London 63
Haiphong 62
Frankfurt am Main 61
Changsha 60
Shanghai 60
São Paulo 60
Chicago 59
Naples 59
Da Nang 57
Bengaluru 56
Atlanta 55
Des Moines 54
Nanchang 52
Tianjin 52
San Francisco 51
Orem 50
Phoenix 50
Mexico City 47
Hebei 45
Montreal 37
Genoa 36
Modena 36
Bari 34
Jiaxing 34
Brussels 33
Verona 33
Burlington 32
Grafing 32
Nuremberg 32
Dearborn 31
Mahé 31
Zhengzhou 31
Ningbo 28
Warsaw 28
Jakarta 27
Redwood City 27
Hangzhou 26
Munich 26
Paris 26
Toronto 26
Amsterdam 25
Bern 25
Moscow 25
Parma 25
Brescia 24
Denver 24
Thái Nguyên 24
Totale 23.202
Nome #
Il suicidio assistito per pazienti con depressione grave. Un’opzione inaccettabile che gli psichiatri devono combattere fermamente 1.164
Hyperthyroidism and depression: a clinical case of atypical thyrotoxicosis manifestation 568
Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis 392
A Heavy Feeling in the Stomach: Neural Correlates of Anxiety in Crohn's Disease 272
A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia 270
Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial. 267
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders. 264
Pet therapy in elderly patients with mental illness. 247
Whole blood and oral fluid microsampling for the monitoring of patients under treatment with antidepressant drugs 245
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges 239
DISABILITÀ INTELLETTIVE: DAL CONCETTO DI DEFICIT A QUELLO DI FUNZIONAMENTO ADATTIVO 239
Occurrence of cognitive impairment after age 90: usefulness and drawbacks of four broadly used concepts. 236
Eating disorders in narcolepsy type 1: Evidence from a cross-sectional Italian study 232
Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. 230
Animal-assisted interventions for elderly patients affected by dementia or psychiatric disorders: a review. 230
Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples. 225
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries 222
Predictive coding in neuropsychiatric disorders: A systematic transdiagnostic review 220
The 5-HT2C receptor as a target for mood disorders. 220
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? 219
Cognitive status, depressive symptoms, and health status as predictors of functional disability among elderly persons with low-to-moderate education: The Faenza Community Aging Study. 217
Le demenze 212
Anxiety symptoms in 74+ community-dwelling elderly: associations with physical morbidity, depression and alcohol consumption 212
COMT and age at onset in mood disorders: a replication and extension study. 210
Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study. 205
3111T/C clock gene polymorphism is not associated with sleep disturbances in untreated depressed patients 203
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients 200
Cognitive Impairment after Age 60: Clinical and Social Correlates in the "Faenza Project" 200
Exploring the impact of childhood trauma on obsessive-compulsive disorder: A systematic review focused on adult populations 198
Increased recognition of depression in primary care. Comparison between primary-care physician and ICD-10 diagnosis of depression. 198
5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies 198
A targeted use of DNA microarrays in the pharmacogenetics of antidepressants: pros and cons 197
Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies 197
Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. 196
Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways 195
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. 192
DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients 192
Prevalence and characteristics of mild cognitive impairment in the general population. Data from an Italian population-based study: The Faenza Project. 191
Sleep disturbances in individuals with first episode psychosis and clinical high-risk states: A systematic review 190
Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder. 190
Never too late to be anxious: validation of the Geriatric Anxiety Inventory, Italian version 190
Vortioxetine treatment-emergent mania in the elderly: a case report 190
Compulsory treatments in eating disorders: a systematic review and meta-analysis 188
Assessing motivation for treatment in eating disorders: psychometric validation of the Italian version of the Autonomous and Controlled Motivation for Treatment Questionnaire (ACMTQ-ITA) 187
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? 187
CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients 187
Suicide attempts in eating disorder subtypes: A meta-analysis of the literature employing DSM-IV, DSM-5, or ICD-10 diagnostic criteria 186
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders 184
Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples. 184
Abelson helper integration site-1 gene variants on major depressive disorder and bipolar disorder 184
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors 183
Still waiting: referral patterns, delays, and key factors in accessing specialized eating disorder treatment in an Italian cohort 183
TAAR 6 and HSP-70 variations associated with bipolar disorder 183
Lack of Association between Interleukin-1 alpha rs1800587 Polymorphism and Alzheimer's Disease in Two Independent European Samples 183
Prevalence and Gender Differences in Late-Life Depression: A Population-Based Study. 182
Sex-specific issues in eating disorders: a clinical and psychopathological investigation 181
Symptoms of depression in late luteal phase dysphoric disorder: a variant of mood disorder? 180
Correlation of a set of gene variants, life events and personality features on adult ADHD severity 180
Alexithymia: phisiopathology, etiology and management 180
TAAR6 variations possibly associated with antidepressant response and suicidal behavior 179
APOE epsilon-4 allele and cytokine production in Alzheimer's disease 176
No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression. 176
Depressive symptomatology is influenced by chronotypes 174
Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project 173
TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression. 173
Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients. 173
Vision and hearing impairments are associated with depressive--anxiety syndrome in Italian elderly. 172
Do the estrogen receptors 1 gene variants influence the temperament and character inventory scores in suicidal attempters and healthy subjects? 172
Personality and Genetics 170
Schizofrenia: genetica, prevenzione e riabilitazione 169
Beyond anorexia and bulimia nervosa: what's "new" in eating disorders? 169
Duration of untreated illness and response to SRI treatment in Obsessive-Compulsive Disorder 168
Thyroid hormones affect recovery from depression during antidepressant treatment 167
The influence of AHI1 variants on the diagnosis and treatment outcome in schizophrenia 167
Miniaturised alternative sampling for the TDM of eating disorder patients under antidepressant treatment 167
Dissecting the determinants of depressive disorders outcome: an in depth analysis of two clinical cases 166
Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol 166
AKAP13, CACNA1, GRIK4 and GRIA1 genetic variations may be associated with haloperidol efficacy during acute treatment. 166
Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer's disease 165
The missing link between philosophy and psychopathology 165
Epigenetic basis of psychiatric disorders: a narrative review 164
Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients 163
Temperament and character of suicide attempters 162
Influence of TAAR6 polymorphisms on response to aripiprazole 162
The impact of heat shock protein 70 gene variations on clinical presentation and outcome in schizophrenic inpatients 162
Schizophrenia: genetics, prevention and rehabilitation 162
Suicide risk in Obsessive-Compulsive Disorder and exploration of risk factors: a systematic review 162
Antidepressant response in the elderly. 160
Different classification systems yield different dementia occurrence among nonagenarians and centenarians. 160
Novel Antidepressants and Panic Disorder: Evidence beyond Current Guidelines 159
Psychopathology of first-episode psychosis in HIV-positive persons in comparison to first-episode schizophrenia: a neglected issue. 159
Effect of the dysbindin gene on antimanic agents in patients with bipolar I disorder 158
Potential benefits of slow titration of paroxetine treatment in an elderly population: eight-week results from a naturalistic setting. 158
Tyrosine Hydroxylase and DOPA Decarboxylase Gene Variants in Personality Traits 158
Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy. 158
Eating Disorders and Disturbed Eating Behaviors Underlying Body Weight Differences in Patients Affected by Endometriosis: Preliminary Results from an Italian Cross-Sectional Study 157
Dysbindin gene (DTNBP1) and schizophrenia in Korean population 157
The 5-HTTLPR polymorphism and eating disorders: a meta-analysis. 156
Estrogen receptor gene 1 variants are not associated with suicidal behavior 156
Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder 156
Totale 20.458
Categoria #
all - tutte 100.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.679


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.934 0 97 229 288 279 177 69 274 109 362 582 468
2022/20233.243 331 444 147 369 242 200 119 202 641 95 287 166
2023/20241.151 75 161 67 127 87 215 99 90 40 81 40 69
2024/20255.319 149 646 340 285 1.087 283 257 167 135 401 330 1.239
2025/202613.785 883 1.441 1.172 1.134 1.385 664 1.379 1.128 2.206 972 808 613
2026/20271.870 1.190 680 0 0 0 0 0 0 0 0 0 0
Totale 37.753